Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2021

01-08-2021 | Gastric Cancer | Original Article

LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis

Authors: Yejia Cui, Rong Pu, Jinjun Ye, Haohai Huang, Dan Liao, Yufeng Yang, Wanchan Chen, Yelin Yao, Yingai He

Published in: Digestive Diseases and Sciences | Issue 8/2021

Login to get access

Abstract

Aim

Long non-coding RNAs serve as key components of competing endogenous RNA (ceRNA) networks that underlie tumorigenesis. We investigated the pathogenic roles of lncRNA FAM230B and its molecular mechanism in gastric cancer (GC).

Method

The levels of FAM230B expression in five gastric cancer cell lines and in human gastric mucosal cells were compared by quantitative RT-PCR. To analyze the function of FAM230B in GC, we overexpressed FAM230B in AGS cells, silenced FAM230B in MGC-803 cells, and tested the effect of FAM230B on tumor growth in nude mice. The interaction between miR-27a-5p and FAM230B was predicted by a bioinformatics analysis and then verified with a dual-luciferase reporter assay. We also further investigated the role and mechanism of FAM230B by forcing overexpression of miR-27a-5p in MGC-803 gastric cancer cells.

Results

We found that FAM230B was highly expressed in gastric cancer cell lines and mainly located in the cytoplasm. FAM230B overexpression promoted the proliferation, migration, and invasion of AGS cells and repressed their apoptosis; it also facilitated tumor growth in vivo. In contrast, FAM230B knockdown suppressed the proliferation, migration, and invasion of MGC0803 cells, but enhanced their apoptosis and inhibited tumor growth in vivo. MiR-27a-5p expression was suppressed by FAM230B overexpression in AGS cells. MiR-27a-5p inhibited the proliferation, migration, and invasion of gastric cancer cells, and promoted the apoptosis of gastric cancer cells by reducing TOP2A (topoisomerase 2 alpha) expression.

Conclusion

Our study showed that lncRNA FAM230B might function to promote GC. FAM230B functioned as a ceRNA by sponging miR-27a-5p and enhancing TOP2A expression.
Literature
1.
go back to reference Berger H, Marques MS, Zietlow R, et al. Gastric cancer pathogenesis. Helicobacter. 2016;21:34–38.CrossRef Berger H, Marques MS, Zietlow R, et al. Gastric cancer pathogenesis. Helicobacter. 2016;21:34–38.CrossRef
2.
go back to reference Figueiredo C, Camargo MC, Leite M, et al. Pathogenesis of gastric cancer: genetics and molecular classification. Curr Top Microbiol Immunol. 2017;400:277–304.PubMed Figueiredo C, Camargo MC, Leite M, et al. Pathogenesis of gastric cancer: genetics and molecular classification. Curr Top Microbiol Immunol. 2017;400:277–304.PubMed
3.
go back to reference Zali H, Rezaeitavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4:175–185.PubMedPubMedCentral Zali H, Rezaeitavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4:175–185.PubMedPubMedCentral
5.
go back to reference Silva AN, Coffa J, Menon V, et al. Frequent coamplification of receptor tyrosine kinase and downstream signaling genes in Japanese primary gastric cancer and conversion in matched lymph node metastasis. Ann Surg. 2018;267:114–121.CrossRef Silva AN, Coffa J, Menon V, et al. Frequent coamplification of receptor tyrosine kinase and downstream signaling genes in Japanese primary gastric cancer and conversion in matched lymph node metastasis. Ann Surg. 2018;267:114–121.CrossRef
6.
go back to reference Lv J, Fan HX, Zhao XP, et al. Long non-coding RNA unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 2016;382:166–175.CrossRef Lv J, Fan HX, Zhao XP, et al. Long non-coding RNA unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells. Cancer Lett. 2016;382:166–175.CrossRef
7.
go back to reference Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109:2093–2100.CrossRef Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109:2093–2100.CrossRef
8.
go back to reference Uszczynska-Ratajczak B, Lagarde J, Frankish A, Guigó R, Johnson R. Towards a complete map of the human long non-coding RNA transcriptome. Nat Rev Genet. 2018;19:535–548.CrossRef Uszczynska-Ratajczak B, Lagarde J, Frankish A, Guigó R, Johnson R. Towards a complete map of the human long non-coding RNA transcriptome. Nat Rev Genet. 2018;19:535–548.CrossRef
9.
go back to reference Alvarez-Dominguez JR, Wenqian H, Bingbing Y, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123:570–581.CrossRef Alvarez-Dominguez JR, Wenqian H, Bingbing Y, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123:570–581.CrossRef
10.
go back to reference Batista PJ, Chang HY. Long Noncoding RNAs: cellular Address Codes in Development and Disease. Cell. 2013;152:1298–1307.CrossRef Batista PJ, Chang HY. Long Noncoding RNAs: cellular Address Codes in Development and Disease. Cell. 2013;152:1298–1307.CrossRef
11.
go back to reference Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nature Rev Genet.. 2013;15:7–21.CrossRef Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nature Rev Genet.. 2013;15:7–21.CrossRef
12.
go back to reference Fitzgerald KA, Caffrey DR. Long noncoding RNAs in innate and adaptive immunity. Curr Opin Immunol. 2014;26:140–146.CrossRef Fitzgerald KA, Caffrey DR. Long noncoding RNAs in innate and adaptive immunity. Curr Opin Immunol. 2014;26:140–146.CrossRef
13.
go back to reference Qin C, Cai H, Qing H, et al. Recent advances on the role of long non-coding RNA H19 in regulating mammalian muscle growth and development. Hereditas.. 2017;39:1150–1157.PubMed Qin C, Cai H, Qing H, et al. Recent advances on the role of long non-coding RNA H19 in regulating mammalian muscle growth and development. Hereditas.. 2017;39:1150–1157.PubMed
14.
go back to reference Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, et al. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol.. 2018;41:585–603.CrossRef Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, et al. The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol.. 2018;41:585–603.CrossRef
15.
go back to reference Han J, Rong LF, Shi CB, et al. Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients. World J Gastroenterol. 2014;20:8139–8150.CrossRef Han J, Rong LF, Shi CB, et al. Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients. World J Gastroenterol. 2014;20:8139–8150.CrossRef
16.
go back to reference Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261.CrossRef Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261.CrossRef
17.
go back to reference Zhao X, Sun Z, Li H, et al. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3′-UTR. Cancer Biomark.. 2017;20:207–216.CrossRef Zhao X, Sun Z, Li H, et al. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3′-UTR. Cancer Biomark.. 2017;20:207–216.CrossRef
18.
go back to reference Zhang K, Shi H, Xi H, et al. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics.. 2017;7:213–227.CrossRef Zhang K, Shi H, Xi H, et al. Genome-Wide lncRNA Microarray Profiling Identifies Novel Circulating lncRNAs for Detection of Gastric Cancer. Theranostics.. 2017;7:213–227.CrossRef
19.
go back to reference Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356:357–366.CrossRef Fang XY, Pan HF, Leng RX, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356:357–366.CrossRef
20.
go back to reference Liu J, Ben Q, Lu E, et al. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer. Cell Death Dis. 2018;9:168.CrossRef Liu J, Ben Q, Lu E, et al. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer. Cell Death Dis. 2018;9:168.CrossRef
21.
go back to reference Zhang G, Li S, Lu J, et al. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer.. 2018;17:87.CrossRef Zhang G, Li S, Lu J, et al. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer.. 2018;17:87.CrossRef
22.
go back to reference Li C, Liang G, Yao W, et al. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer. Oncol Rep. 2016;35:1529–1540.CrossRef Li C, Liang G, Yao W, et al. Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer. Oncol Rep. 2016;35:1529–1540.CrossRef
23.
go back to reference Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113:569–573.CrossRef Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113:569–573.CrossRef
24.
go back to reference Liu XH, Sun M, Nie FQ, et al. LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer.. 2014;13:92.CrossRef Liu XH, Sun M, Nie FQ, et al. LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer.. 2014;13:92.CrossRef
25.
go back to reference Mizuno K, Mataki H, Arai T, et al. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. J Human Genet.. 2017;62:671–678.CrossRef Mizuno K, Mataki H, Arai T, et al. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. J Human Genet.. 2017;62:671–678.CrossRef
26.
go back to reference Barros-Silva D, Costa-Pinheiro P, Duarte H, et al. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis. Cell Death Dis. 2018;9:167.CrossRef Barros-Silva D, Costa-Pinheiro P, Duarte H, et al. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis. Cell Death Dis. 2018;9:167.CrossRef
27.
go back to reference Song J, Ye A, Jiang E, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119:6665–6673.CrossRef Song J, Ye A, Jiang E, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119:6665–6673.CrossRef
28.
go back to reference Guo W, You X, Xu D, et al. PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. Carcinogenesis. 2016;37:397–407.CrossRef Guo W, You X, Xu D, et al. PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. Carcinogenesis. 2016;37:397–407.CrossRef
29.
go back to reference Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1 and DNMT1. Cancer Res. 2016;76:6299–6310.CrossRef Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1 and DNMT1. Cancer Res. 2016;76:6299–6310.CrossRef
30.
go back to reference Zhou X, Ye F, Yin C, et al. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer. Cellular Physiol Biochem.. 2015;36:1440–1452.CrossRef Zhou X, Ye F, Yin C, et al. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer. Cellular Physiol Biochem.. 2015;36:1440–1452.CrossRef
31.
go back to reference Cheng Y, Du L, Jiao H, et al. Mmu-miR-27a-5p-dependent upregulation of MCPIP1 inhibits the inflammatory response in LPS-induced RAW2647 macrophage cells. BioMed Res Int. 2015;2015:1–10. Cheng Y, Du L, Jiao H, et al. Mmu-miR-27a-5p-dependent upregulation of MCPIP1 inhibits the inflammatory response in LPS-induced RAW2647 macrophage cells. BioMed Res Int. 2015;2015:1–10.
32.
go back to reference Romay MC, Nam C, Becker SN, et al. Regulation of NF-κB signaling by oxidized glycerophospholipid and IL-1β induced miRs-21-3p and -27a-5p in human aortic endothelial cells. J Lipid Res. 2015;56:38–50.CrossRef Romay MC, Nam C, Becker SN, et al. Regulation of NF-κB signaling by oxidized glycerophospholipid and IL-1β induced miRs-21-3p and -27a-5p in human aortic endothelial cells. J Lipid Res. 2015;56:38–50.CrossRef
33.
go back to reference Li X, Liu Y, Chen W, et al. TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer. Oncotarget. 2014;5:9498–9513.CrossRef Li X, Liu Y, Chen W, et al. TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer. Oncotarget. 2014;5:9498–9513.CrossRef
34.
go back to reference Tarpgaard LS, Qvortrup C, NygaRd SB, et al. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. BMC Cancer. 2016;16:91.CrossRef Tarpgaard LS, Qvortrup C, NygaRd SB, et al. A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. BMC Cancer. 2016;16:91.CrossRef
35.
go back to reference Pei YF, Yin XM, Liu XQ. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochim Biophys Acta. 2017;1864:197–207.CrossRef Pei YF, Yin XM, Liu XQ. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochim Biophys Acta. 2017;1864:197–207.CrossRef
36.
go back to reference de Aguiar VG, Segatelli V, Macedo ALV, et al. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer. Future Oncol. 2019;15:401–408.CrossRef de Aguiar VG, Segatelli V, Macedo ALV, et al. Signet ring cell component, not the Lauren subtype, predicts poor survival: an analysis of 198 cases of gastric cancer. Future Oncol. 2019;15:401–408.CrossRef
37.
go back to reference Ha TK, An JY, Youn HK, et al. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol. 2008;15:508–513.CrossRef Ha TK, An JY, Youn HK, et al. Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol. 2008;15:508–513.CrossRef
Metadata
Title
LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis
Authors
Yejia Cui
Rong Pu
Jinjun Ye
Haohai Huang
Dan Liao
Yufeng Yang
Wanchan Chen
Yelin Yao
Yingai He
Publication date
01-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06581-z

Other articles of this Issue 8/2021

Digestive Diseases and Sciences 8/2021 Go to the issue

Stanford Multidisciplinary Seminars

Gas Bubbles: A Persistent Problem with Immunotherapy

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine